Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Patrycja Gralewska"'
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2020)
Abstract Ovarian cancer is one of the most lethal gynecologic malignancies reported throughout the world. The initial, standard-of-care, adjuvant chemotherapy in epithelial ovarian cancer is usually a platinum drug, such as cisplatin or carboplatin,
Externí odkaz:
https://doaj.org/article/89b35b142559423aabf3d1ac093f5154
Publikováno v:
Cells, Vol 11, Iss 12, p 1889 (2022)
Olaparib is a poly (ADP-ribose) polymerase inhibitor (PARPi) that inhibits PARP1/2, leading to replication-induced DNA damage that requires homologous recombination repair. Olaparib is often insufficient to treat BRCA-mutated (BRCAMUT) and BRCA wild-
Externí odkaz:
https://doaj.org/article/636c2ed57b2e4e9f866ae2502ea22d39
Publikováno v:
Cancers
Cancers, Vol 13, Iss 2690, p 2690 (2021)
Cancers, Vol 13, Iss 2690, p 2690 (2021)
Simple Summary Ovarian cancer is the leading cause of death from gynecological malignancies. Recent studies have focused on ovarian cancer-associated microRNAs that play strong regulatory roles in various cellular processes. While miRNAs have been sh
Publikováno v:
Acta Universitatis Lodziensis. Folia Biologica et Oecologica. 17:5-6
Autor:
Patrycja Gralewska, Izabela Szymczak-Pajor, Jacek Kasznicki, Krzysztof Fleszar, Agnieszka Śliwińska
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 73
Sulfonylureas (SUs) are suggested to accelerate the pancreatic β-cells mass loss via apoptosis. However, little is known whether calpains mediate this process. The aim of the present study is to evaluate the involvement of calpains in SUs-induced de
Autor:
Jerzy Ostrowski, Patrycja Gralewska, Agnieszka Marczak, Michal Mikula, Aneta Rogalska, Agnieszka Śliwińska, Arkadiusz Gajek
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 9715, p 9715 (2020)
Volume 21
Issue 24
International Journal of Molecular Sciences, Vol 21, Iss 9715, p 9715 (2020)
Volume 21
Issue 24
Poly (ADP-ribose) polymerase inhibitor (PARPi, olaparib) impairs the repair of DNA single-strand breaks (SSBs), resulting in double-strand breaks (DSBs) that cannot be repaired efficiently in homologous recombination repair (HRR)-deficient cancers su
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2020)
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2020)
Ovarian cancer is one of the most lethal gynecologic malignancies reported throughout the world. The initial, standard-of-care, adjuvant chemotherapy in epithelial ovarian cancer is usually a platinum drug, such as cisplatin or carboplatin, combined
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 19
International Journal of Molecular Sciences, Vol 22, Iss 10557, p 10557 (2021)
Volume 22
Issue 19
International Journal of Molecular Sciences, Vol 22, Iss 10557, p 10557 (2021)
This study examined the effect of combination treatment with the poly (ADP-ribose) polymerase inhibitor olaparib and metformin on homologous recombination (HR)-proficient epithelial ovarian cancer (EOC). Ovarian cancer cell lines (OV-90 and SKOV-3) w
Publikováno v:
Acta Ophthalmologica. 97
Autor:
Izabela Szymczak-Pajor, Krzysztof Fleszar, Jacek Kasznicki, Patrycja Gralewska, Agnieszka Śliwińska
Publikováno v:
Medical University of Lodz, Poland. PublicUM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::117c1a99de9b9de320b780b1719c5366
https://journals.viamedica.pl/diabetologia_praktyczna/article/view/70603
https://journals.viamedica.pl/diabetologia_praktyczna/article/view/70603